Industry News

Johnson & Johnson announces major commitment to expedite ebola vaccine development
Arbor Pharmaceuticals Announces FDA Approval of Sotylize
WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine
HHS Secretary announces $840 million initiative to improve patient care and lower costs
Johnson & Johnson announces major commitment to expedite ebola vaccine development
Contract Packaging Resources, Inc. Issues a Voluntary Nationwide Recall of Assured Brand Naproxen Sodium Tablets Due to Packaging Mix-Up
CHI's Latest Report Shows Modest Improvement in FDA Medical Device Review Times
Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge Surgical Leads For The Precision Spectra Spinal Cord Stimulator (SCS) System World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for Patients
Dignitana AB in meeting with the Food and Drug Administration (FDA)
Dignitana AB in meeting with the Food and Drug Administration (FDA)
Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge� Surgical Leads For The Precision Spectra� Spinal Cord Stimulator (SCS) System World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for
Chinese experimental drug sent out to Ebola-hit Africa
Chinese experimental drug sent out to Ebola-hit Africa
U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination
U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination
Boehringer Ingelheim's OFEV Approved by FDA as a Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Shire eyes deals using $1.6bn AbbVie windfall
FDA OKs Eylea (aflibercept) Injection
Gay-rights group backs use of HIV-prevention pill
FDA Approves B. Braun Injection Containers
Direct Flow Medical Gets CE Mark for Transfemoral Aortic Heart Valve Delivery System
Chimerix gets FDA OK to test drug for Ebola
Chimerix gets FDA OK to test drug for Ebola
FDA Approves Labeling With Abuse-Deterrent Features For Third Extended-Release Opioid Analgesic
BRIEF: HHS helps fund development of new Ebola vaccine